10.1161/CIRCULATIONAHA.120.050686 11 KimM
Verzehrempfehlung nicht berschreiten
Participants were randomly assigned in a 1:1:1 ratio to receive weekly subcutaneous injections of efpeglenatide (4 mg or 6 mg) or placebo
GLP-1 medications are engineered to mimic glucagon-like peptide-1, he explains, a hormone the gut naturally releases after a meal. However, while the version produced by the body peaks and clears within minutes, the medication version keeps that signal active for days, he adds
Possible Side Effects Epithalon is generally well-tolerated in preclinical and limited human observational studies
However, rapid weight loss from GLP-1 therapy may lower hemoglobin temporarily, so blood banks will check your levels before donation to ensure you meet the minimum threshold